LEVOSIMENDAN for Pulmonary hypertension: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 10 adverse event reports in the FDA FAERS database where LEVOSIMENDAN was used for Pulmonary hypertension.
Most Reported Side Effects for LEVOSIMENDAN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 64 | 35.0% | 10 | 41 |
| Cardiac failure | 37 | 20.2% | 10 | 30 |
| Hypotension | 37 | 20.2% | 6 | 28 |
| Off label use | 28 | 15.3% | 0 | 19 |
| Respiratory failure | 27 | 14.8% | 4 | 16 |
| Constipation | 16 | 8.7% | 0 | 16 |
| Hypothyroidism | 16 | 8.7% | 0 | 16 |
| Ejection fraction decreased | 15 | 8.2% | 4 | 14 |
| Jugular vein distension | 14 | 7.7% | 0 | 14 |
| Pulmonary hypertension | 13 | 7.1% | 0 | 11 |
| Condition aggravated | 12 | 6.6% | 8 | 11 |
| Cardiogenic shock | 11 | 6.0% | 1 | 10 |
| Therapy non-responder | 11 | 6.0% | 4 | 6 |
| Acidosis | 10 | 5.5% | 0 | 0 |
| Pallor | 10 | 5.5% | 0 | 1 |
Other Indications for LEVOSIMENDAN
Product used for unknown indication (47)
Cardiac failure (29)
Cardiac failure congestive (18)
Cardiogenic shock (15)
Cardiac failure acute (9)
Haemodynamic instability (5)
Hypotension (5)
Other Drugs Used for Pulmonary hypertension
AMBRISENTAN (18,885)
TREPROSTINIL (10,034)
MACITENTAN (5,228)
RIOCIGUAT (3,837)
SILDENAFIL (3,761)
SELEXIPAG (2,500)
EPOPROSTENOL (2,486)
TADALAFIL (2,430)
BOSENTAN (2,337)
ILOPROST (1,123)